Sernova Corp T.SVA

Neurological diseases

[Redbaron2211]

We know money will be directed toward the 3 current indications but Philp keeps mentioning potential neurological diseases.   I'm curious what diseases he is referring to.  Parkinsons would make sense with implanting dopamine producing cells in the cell pouch.  Would be interesting to see a proof of concept not that we need any more indications but even more talk about the possibilities would be helpful.

[BioTeck]

Parkinsons used to be on SVA slide decks many moons ago. As far as I can see, all materials relating to Parkinsons from their website/presentations has been removed. What about focusing on current indications and deals instead of looking for more uses? Maybe they can give it out for free to some Parkinsons companies and sign NDA's that they can't use their names but the companies can use

[Redbaron2211]

Bio as I said just curious as it was mentioned in the presentation, this is a long way out regardless but maybe with a larger budget some of this will be elaborated on again and possibly there are more indications.  Better than the banter that normally fills the board. As for Sigilon they are still 2x our MC and pre clinical.  I'm not surprised to see SGTX drop as they are a long